US weighs new route of ad­min­is­tra­tion for mon­key­pox vac­cine as cas­es climb — re­port

Less than a week af­ter HHS Sec­re­tary Xavier Be­cer­ra de­clared mon­key­pox a na­tion­al health emer­gency, re­ports have emerged that the US plans to ex­tend its vac­cine sup­ply by opt­ing for a dif­fer­ent route of ad­min­is­tra­tion.

Of­fi­cials are ex­pect­ed to call for in­tra­der­mal in­jec­tion of Bavar­i­an Nordic’s Jyn­neos vac­cine — the on­ly shot ap­proved specif­i­cal­ly for mon­key­pox in the US — as op­posed to sub­cu­ta­neous in­jec­tion, un­named sources told both the New York Times and Wash­ing­ton Post on Tues­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER